Profil
Hilmar Meek Warenius was the founder of Theryte Ltd. (founded in 1998) where he held the title of Chief Medical Officer until 2012.
He was also the founder of Pronec Ltd. (founded in 2015) where he held the title of Director until 2022.
Currently, Dr. Warenius is a Professor at The University of Southampton.
In the past, he worked as the Director-Medical Oncology Research Unit at The University of Liverpool.
Postes actifs de Hilmar Meek Warenius
| Sociétés | Poste | Début |
|---|---|---|
The University of Southampton
The University of Southampton Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Anciens postes connus de Hilmar Meek Warenius
| Sociétés | Poste | Fin |
|---|---|---|
Pronec Ltd.
Pronec Ltd. Miscellaneous Commercial ServicesCommercial Services Develops cancer therapy | Fondateur | 15/05/2022 |
The University of Liverpool
The University of Liverpool Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Theryte Ltd.
Theryte Ltd. Pharmaceuticals: MajorHealth Technology Operates as a drug discovery and development company that is committed to bringing new cancer treatments to market | Fondateur | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
The University of Liverpool
The University of Liverpool Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Southampton
The University of Southampton Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Theryte Ltd.
Theryte Ltd. Pharmaceuticals: MajorHealth Technology Operates as a drug discovery and development company that is committed to bringing new cancer treatments to market | Health Technology |
Pronec Ltd.
Pronec Ltd. Miscellaneous Commercial ServicesCommercial Services Develops cancer therapy | Commercial Services |
















